Shattuck Labs Announces Participation in Upcoming March Investor Conferences

By Benzinga5 days ago

AUSTIN, TX and DURHAM, NC, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that Shattuck management will participate in two upcoming investor conferences.

Presentation Details

Conference: Cowen 41st Annual Health Care Conference

Format: Ovarian Cancer Panel discussion

Presenter: Taylor Schreiber, M.D., Ph.D., Shattuck's Chief Executive Officer

Date: March 2, 2021

Time: 12:50 p.m. EST

Webcast Link: The panel discussion will be available live to conference attendees

Conference: Oppenheimer 31st Annual Healthcare Conference

Presenter: Andrew Neill, Shattuck's ...

Full story available on Benzinga.com

Continue read on benzinga.com